Skip to main content
John Donovan, MD, Anesthesiology, Oakland, CA

JohnDonovanMDMBA

Anesthesiology Oakland, CA

Physician

Dr. Donovan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Donovan's full profile

Already have an account?

  • Office

    350 Hawthorne Ave
    Oakland, CA 94609
    Phone+1 510-666-0854
    Fax+1 510-666-1192

Summary

  • John Donovan, MD, is an Anesthesiologist based in Oakland, CA. He completed his residency in Anesthesiology at the University of California San Francisco between 1996 and 1999, having graduated from Georgetown University School of Medicine in 1992. Donovan has multiple significant publications to his name, one of which has been cited 98 times. His research mainly focuses on the management of postsurgical pain and the use of the novel capsaicin prodrug, vocacapsaicin.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Anesthesiology, 1996 - 1999
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - 2026
  • RI State Medical License
    RI State Medical License 1995 - 1997
  • UT State Medical License
    UT State Medical License 1994 - 1994
  • American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

Press Mentions

  • Concentric Analgesics Announces Additional Positive Results from Phase 2 Clinical Trial of Vocacapsaicin (CA-008) in Total Knee Arthroplasty Surgery
    Concentric Analgesics Announces Additional Positive Results from Phase 2 Clinical Trial of Vocacapsaicin (CA-008) in Total Knee Arthroplasty SurgeryJanuary 26th, 2021
  • Concentric Analgesics Announces Positive Topline Results from Phase 1b Clinical Trial for CA-008 in Post-Surgical Pain
    Concentric Analgesics Announces Positive Topline Results from Phase 1b Clinical Trial for CA-008 in Post-Surgical PainMay 14th, 2018
  • Concentric Analgesics Deepens Leadership Team to Advance Non-Opioid Pain Portfolio
    Concentric Analgesics Deepens Leadership Team to Advance Non-Opioid Pain PortfolioApril 3rd, 2018
  • Join now to see all